King Pharmaceuticals and Wyeth have amended and restated their co-promotion agreement for King’s Altace (ramipril), an angiotensin converting enzyme (ACE) inhibitor to treat high blood pressure.

One-Third of Surveyed Payers Identify Altace as the Most Efficacious Therapy for Diabetic Nephropathy, According to Findings from Decision Resources BURLINGTON, Mass.--(BUSINESS WIRE)-- Decision ...

Feb. 16, 2005 — The U.S. Food and Drug Administration (FDA) approved in November 2004 revisions to safety labeling to advise healthcare professionals of the following changes: glycopyrrolate ...

Nov. 11, 2005 — The U.S. Food and Drug Administration (FDA) has approved first-time generic formulations of glimepiride 1-, 2-, and 4-mg tablets and first-time doses of 3-, 6-, and 8-mg tablets for ...

A federal appeals court has reversed a decision made by the U.S. District Court for the Eastern District of Virginia, which had found that Lupin Pharmaceuticals had infringed on a compound patent of ...

NEW YORK, Sept 12 (Reuters) - King Pharmaceuticals Inc said on Wednesday it would seek a rehearing with the U.S. federal appeals court that ruled the patent on King's biggest product, high blood ...

US drug giant Wyeth has decided to close the curtains on its deal to co-market King Pharmaceutical’s flagship hypertension drug, Altace. The company is planning to return all rights to King in January ...

Generic altace used to treat hypertension is a hypotensive agent. Generic for altace ramparil is also used to reduce heart attacks and strokes by lowering the blood pressure. Some of the serious side ...

King Pharmaceuticals has launched a tablet formulation of Altace (ramipril). The tablets will be available in 1.25mg, 2.5mg, 5mg, and 10mg dosage strengths and are indicated for the treatment of ...

- an ACE inhibitor (trade name Altace) used to treat high blood pressure or in some patients who have had a heart attack ...

NEW YORK, Nov 11 (Reuters) - Cobalt Pharmaceuticals has told King Pharmaceuticals Inc that it intends to launch a generic version of King's top-selling blood-pressure drug Altace, according to King.